New MASCC/ISOO/ASCO Guidelines: Salivary Gland Hypofunction and Xerostomia

2021     Our newest guidelines, created jointly with ISOO and ASCO, address the prevention and management of salivary gland hypofunction and xerostomia induced by non-surgical cancer therapies.

You can read the full paper or download a PDF summary on our Guidelines page.

 

Share this post:

Comments on "New MASCC/ISOO/ASCO Guidelines: Salivary Gland Hypofunction and Xerostomia"

Comments 0-0 of 0

Please login to comment